Acquisitions Acquisitions (Tables)

9 Months Ended

Sep. 27, 2019

The following table summarizes the provisional fair value estimates of the assets acquired and liabilities assumed of Principal and Non-Principal Countries that have been transferred to ASP as of September 27, 2019; we did not acquire accounts receivable or accounts payable from Johnson & Johnson:



	Advanced Sterilization Products
Inventories	$	168.8
Property, plant and equipment	45.2
Goodwill	1,385.2
Other intangible assets, primarily customer relationships, trade names and technology	1,126.5
Other assets and liabilities, net	(90.3		)
Total consideration allocated to Principal Countries	2,635.4
Prepaid acquisition asset related to Non-Principal Countries	64.6
Net cash consideration	$	2,700.0

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:



Accounts receivable	$	39.8
Inventories	16.2
Property, plant and equipment	9.5
Goodwill	454.6
Other intangible assets	252.2
Other assets and liabilities, net	(88.7		)
Net cash consideration	$	683.6

Pro Forma Information

The pro forma information is presented for informational purposes only and is not indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions except per share amounts):



	Three Months Ended				Nine Months Ended
	September 27, 2019		September 28, 2018		September 27, 2019		September 28, 2018
Sales	$	1,877.6	$	1,856.8	$	5,614.7	$	5,558.9
Net earnings	$	240.3	$	141.9	$	626.1	$	447.0
Diluted net earnings per share	$	0.71	$	0.40	$	1.84	$	1.26